Logo image of PMX

PIMCO MUNI INCOME FUND III (PMX) Stock Price, Quote, News and Overview

NYSE:PMX - New York Stock Exchange, Inc. - US72201A1034 - Currency: USD

6.79  0 (0%)

Fundamental Rating

1

Overall PMX gets a fundamental rating of 1 out of 10. We evaluated PMX against 0 industry peers in the Unkown industry. Both the profitability and financial health of PMX have multiple concerns. PMX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PMX has reported negative net income.
In the past year PMX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PMX reported negative net income in multiple years.
Each year in the past 5 years PMX had a positive operating cash flow.
PMX Yearly Net Income VS EBIT VS OCF VS FCFPMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA -0.7%
ROE -0.82%
ROIC 1.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMX Yearly ROA, ROE, ROICPMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

PMX's Operating Margin has declined in the last couple of years.
PMX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 51.45%
PM (TTM) N/A
GM 68.05%
OM growth 3Y-14.16%
OM growth 5Y-8.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.24%
PMX Yearly Profit, Operating, Gross MarginsPMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

There is no outstanding debt for PMX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PMX Yearly Shares OutstandingPMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PMX Yearly Total Debt VS Total AssetsPMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

PMX has an Altman-Z score of 1.97. This is not the best score and indicates that PMX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of PMX is 2.15, which is a good value as it means it would take PMX, 2.15 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.14 indicates that PMX is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for PMX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.15
Altman-Z 1.97
ROIC/WACCN/A
WACCN/A
PMX Yearly LT Debt VS Equity VS FCFPMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.00 indicates that PMX may have some problems paying its short term obligations.
PMX has a Quick Ratio of 0.00. This is a bad value and indicates that PMX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
PMX Yearly Current Assets VS Current LiabilitesPMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

PMX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.63%.
The Revenue has decreased by -1.05% in the past year.
The Revenue has been decreasing by -6.74% on average over the past years.
EPS 1Y (TTM)-115.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.35%
Revenue 1Y (TTM)-1.05%
Revenue growth 3Y-3.92%
Revenue growth 5Y-6.74%
Sales Q2Q%-0.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMX Yearly Revenue VS EstimatesPMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PMX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMX Price Earnings VS Forward Price EarningsPMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 8.41
EV/EBITDA N/A
PMX Per share dataPMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

PMX has a Yearly Dividend Yield of 5.35%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.43, PMX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

The dividend of PMX decreases each year by -5.30%.
PMX has been paying a dividend for at least 10 years, so it has a reliable track record.
PMX has decreased its dividend recently.
Dividend Growth(5Y)-5.3%
Div Incr Years0
Div Non Decr Years1
PMX Yearly Dividends per sharePMX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

PMX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-480.48%
EPS Next 2YN/A
EPS Next 3YN/A
PMX Yearly Income VS Free CF VS DividendPMX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

More info and screens

PIMCO MUNI INCOME FUND III

NYSE:PMX (6/27/2025, 8:04:00 PM)

6.79

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners26.86%
Inst Owner Change7.17%
Ins Owners0.02%
Ins Owner Change0%
Market Cap227.06M
Analysts0
Price TargetN/A
Short Float %0.2%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend0.66
Dividend Growth(5Y)-5.3%
DP-480.48%
Div Incr Years0
Div Non Decr Years1
Ex-Date06-12 2025-06-12 (0.033)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.32
P/FCF 8.41
P/OCF 8.41
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.81
FCFY11.89%
OCF(TTM)0.81
OCFY11.89%
SpS0.66
BVpS12.17
TBVpS12.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -0.82%
ROCE 2.43%
ROIC 1.92%
ROICexc 1.92%
ROICexgc 1.94%
OM 51.45%
PM (TTM) N/A
GM 68.05%
FCFM 122.73%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-14.16%
OM growth 5Y-8.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.24%
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.67
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 1.97
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.05%
Revenue growth 3Y-3.92%
Revenue growth 5Y-6.74%
Sales Q2Q%-0.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.21%
EBIT growth 3Y-17.52%
EBIT growth 5Y-14.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3Y55.2%
FCF growth 5Y56.35%
OCF growth 1Y-40%
OCF growth 3Y55.2%
OCF growth 5Y56.35%